Contact information
ORCID ID
0000-0001-9454-1382
Research groups
Daniel Plotkin
Project Manager
Daniel joined the Nuffield Department of Clinical Neurosciences as Project Manager of the national ALS/MND C9orf72 Cohort study ('ACORN') in October 2022, tasked with establishing a national register of motor neuron disease patients and family members carrying the C9orf72 gene mutation. This register will be pivotal in supporting the development of therapeutic strategies and neurochemical biomarkers for ALS. Daniel also manages the Oxford GENFI 3 study, focused on genetic factors leading to Frontotemporal dementia (FTD).
SELECTED PUBLICATIONS
Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.
Docherty AB, Harrison EM et al British Medical Journal (BMJ) 2020 May 22 https://doi.org/10.1136/bmj.m1985
What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol.
Sigfrid L et al British Medical Journal (BMJ) Open. 2021 Mar 10;11(3):e043887. PMID: 33692181
Global outbreak research: harmony not hegemony.
ISARIC clinical characterisation group. The Lancet Infect Dis. 2020 Jul;20(7):770-772. Epub 2020 Jun 2.
PMID: 32502433
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
Thomas M Drake et al. The Lancet (2021) https://doi.org/10.1016/S0140-6736(21)00799-6